clobazam (generic) — Medica
Lennox-Gastaut syndrome
Initial criteria
- age ≥ 2 years
- Patient has tried and/or is concomitantly receiving ONE of the following: (a) at least two other antiseizure medications OR (b) one of lamotrigine, topiramate, rufinamide, felbamate, Fintepla (fenfluramine oral solution), or Epidiolex (cannabidiol oral solution)
- Clobazam is prescribed by or in consultation with a neurologist
Reauthorization criteria
- Patient is currently receiving clobazam and is responding to therapy, as determined by the prescriber (e.g., reduced seizure severity, frequency, and/or duration from baseline)
Approval duration
1 year